Почему мозг устает и падает концентрация | Владимир Алипов
Vladimir Alipov answers viewer questions about brain fatigue during concentration, flat feet and exercise recommendations, and the health risks associated with tall stature. He explains that mental fatigue is likely caused by glucose depletion in neurons, and that skill automation frees up working memory over time.
Summary
The video opens with Vladimir Alipov addressing why the brain gets tired and concentration drops during prolonged mental activity. He explains that the most plausible hypothesis is that energy resources — specifically glucose — become depleted in neurons. When neurons are activated, glucose concentration in the mitochondrial space drops sharply. Sustained concentration requires a large number of neuronal groups to remain active simultaneously, which is essentially what working memory is. He notes that working memory is limited both by the number of elements it can hold and by the duration and intensity of use.
Alipov then discusses how endurance in cognitive tasks improves not through biological changes like new dendrites or mitochondria, but through automation. As tasks become more practiced, they no longer require working memory resources. He uses the example of learning to drive a car: at first, every action demands full conscious attention, but over time, driving becomes automatic, freeing up attention for other things.
The second topic involves a viewer question about flat feet and running pain. Alipov advises that flat feet don't necessarily need to be 'cured' — proper foot positioning through orthopedic insoles is often sufficient. For overweight individuals, he recommends starting with low-impact activities like swimming or cycling rather than running, to reduce joint stress. He also emphasizes the importance of soft surfaces and proper footwear.
The final topic addresses concerns from a 196 cm tall viewer about reduced life expectancy. Alipov explains that the key cardiovascular risk for tall people is the increased strain on the heart required to pump blood upward against greater height. He notes that serious life expectancy reductions are more associated with heights exceeding 2 meters, particularly in individuals with conditions like somatotropinoma or acromegaly. He also warns that high-intensity activities like CrossFit can increase the risk of cardiomegaly regardless of height, but the risks are amplified for tall individuals.
Key Insights
- Alipov argues that mental fatigue during concentration is most likely caused by glucose depletion in the mitochondrial space of neurons, as any neuronal group activation causes a sharp drop in local glucose concentration.
- Alipov claims that cognitive endurance improves primarily through task automation rather than biological changes — once a skill is automated, it no longer occupies working memory, freeing resources for other tasks.
- Alipov states that for overweight people, running should be avoided initially in favor of pool exercises or cycling, and that even healthy, non-overweight people can experience joint and back pain from walking long distances on hard surfaces without orthopedic insoles.
- Alipov argues that the primary health risk for tall people is cardiovascular — the heart must work harder to pump blood upward over greater height, increasing the likelihood of cardiomegaly, ischemic heart disease, and heart failure.
- Alipov contends that significant life expectancy reductions are mainly associated with heights well above 2 meters or with pathological growth conditions like somatotropinoma and acromegaly, suggesting that the cause of extreme height matters more than the height itself.
Topics
Transcript
[0:00] When is the lecture on glutamate and GABA? What do you want to know about glutamate and GABA ? Why do mistakes and fatigue occur when we engage in one activity that requires long periods of concentration ? Do new dendrites grow there with an increase in mitochondria to increase endurance? Look, well, first of all, why are we running out of this resource, right? Why do we get tired when we do something? There are many hypotheses. Basically, the most plausible thing there [0:30] seems to be that some kind of energy resources in neurons are running out. And most likely it's just glucose. We know that, in general, any activation of neurons of any group leads to…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Нейробиолог Владимир Алипов: лучшее
Картезианский театр и бесконечный гомункулус в голове | Владимир Алипов
The speaker explains the concept of the 'Cartesian Theater' — a philosophical metaphor originating with Descartes — where conscious experience arises when unconscious brain processes 'step onto a stage' observed by an inner homunculus. He then critiques the infinite regress problem this creates (who observes the observer?) and connects it to Baars' Global Workspace Theory, which offers a similar theatrical metaphor but without requiring a homunculus audience.
Как измеряют психоделический опыт: шкалы, эффекты | Владимир Алипов
Vladimir Alipov discusses scientific scales used to measure psychedelic experiences, covering perceptual phenomena like synesthesia, depersonalization, and time distortion. He explains the concept of 'set and setting' as key determinants of whether a psychedelic experience is positive or negative. He also briefly addresses non-pharmacological alternatives for achieving transcendental states.
Стадии психоделического опыта от света до узоров | Владимир Алипов
Vladimir Alipov presents a structured breakdown of the stages of psychedelic experience, focusing on DMT and psilocybin. He describes the progression from enhanced sensory perception at the threshold level to geometric visual patterns at the 'chrysanthemum' stage, drawing connections between these phenomena and the fundamental architecture of the human brain.
Психоделики и шизофрения: мифы, риски, факты | Владимир Алипов
Vladimir Alipov discusses the historical misconception that psychedelics are 'psychotomimetics' that cause psychosis, examining the actual risks of psychedelics in relation to schizophrenia. He argues that while psychedelics rarely cause psychosis in healthy individuals, people with a hereditary predisposition to schizophrenia may be at elevated risk, and that research was largely halted due to political stigma in the US.
Психоделики без зависимости, но синтетика убивает | Владимир Алипов
Vladimir Alipov discusses the safety profile of natural and semi-synthetic psychedelics, noting they do not cause addiction or fatal overdoses based on research and large-scale use among hippies. He contrasts this with synthetic psychedelics, which carry serious risks including death, citing a real case of a fatal outcome from a synthetic compound called Bromo-Dragonfly.